| Year |
Citation |
Score |
| 2017 |
Bressy C, Hastie E, Grdzelishvili VZ. Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy. Molecular Therapy Oncolytics. 5: 20-40. PMID 28480326 DOI: 10.1016/j.omto.2017.03.002 |
0.676 |
|
| 2016 |
Hastie E, Cataldi M, Moerdyk-Schauwecker MJ, Felt SA, Steuerwald N, Grdzelishvili VZ. Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Oncotarget. PMID 27533247 DOI: 10.18632/Oncotarget.11202 |
0.721 |
|
| 2015 |
Hastie E, Samulski RJ. Recombinant adeno-associated virus vectors in the treatment of rare diseases. Expert Opinion On Orphan Drugs. 3: 675-689. PMID 27668135 DOI: 10.1517/21678707.2015.1039511 |
0.329 |
|
| 2015 |
Wang M, Crosby A, Hastie E, Samulski JJ, McPhee S, Joshua G, Samulski RJ, Li C. Prediction of adeno-associated virus neutralizing antibody activity for clinical application. Gene Therapy. PMID 26125606 DOI: 10.1038/Gt.2015.69 |
0.31 |
|
| 2015 |
Hastie E, Cataldi M, Steuerwald N, Grdzelishvili VZ. An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells. Virology. 483: 126-40. PMID 25965802 DOI: 10.1016/J.Virol.2015.04.017 |
0.725 |
|
| 2015 |
Hastie E, Samulski RJ. Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective. Human Gene Therapy. 26: 257-65. PMID 25807962 DOI: 10.1089/Hum.2015.025 |
0.345 |
|
| 2013 |
Hastie E, Besmer DM, Shah NR, Murphy AM, Moerdyk-Schauwecker M, Molestina C, Roy LD, Curry JM, Mukherjee P, Grdzelishvili VZ. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma. Journal of Virology. 87: 10283-94. PMID 23864625 DOI: 10.1128/Jvi.01412-13 |
0.704 |
|
| 2013 |
Hastie E, Cataldi M, Marriott I, Grdzelishvili VZ. Understanding and altering cell tropism of vesicular stomatitis virus. Virus Research. 176: 16-32. PMID 23796410 DOI: 10.1016/J.Virusres.2013.06.003 |
0.742 |
|
| 2013 |
Moerdyk-Schauwecker M, Shah NR, Murphy AM, Hastie E, Mukherjee P, Grdzelishvili VZ. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. Virology. 436: 221-34. PMID 23246628 DOI: 10.1016/J.Virol.2012.11.014 |
0.701 |
|
| 2012 |
Hastie E, Grdzelishvili VZ. Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. The Journal of General Virology. 93: 2529-45. PMID 23052398 DOI: 10.1099/Vir.0.046672-0 |
0.74 |
|
| 2011 |
Moerdyk-Schauwecker M, Destephanis D, Hastie E, Grdzelishvili VZ. Detecting protein-protein interactions in vesicular stomatitis virus using a cytoplasmic yeast two hybrid system. Journal of Virological Methods. 173: 203-12. PMID 21320532 DOI: 10.1016/J.Jviromet.2011.02.006 |
0.677 |
|
| Show low-probability matches. |